Back to Search
Start Over
Table S2 from First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Change and end of treatment values for albumin, hemoglobin, and absolute lymphocytes among the 32 patients are summarized below. Abbreviations: SD, stable disease.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....222f3a5240c21531a713b6b4c6fc53ba
- Full Text :
- https://doi.org/10.1158/1078-0432.22471070.v1